SCHOLAR ROCK HOLDING CORPORATION - PMDA AGREES NO ADDITIONAL CLINICAL STUDIES REQUIRED; SCHOLAR ROCK TO SUBMIT APITEGROMAB JNDA BY YE 2026

Reuters · 2d ago

Please log in to view news